Howard Marks Oaktree Capital Management
Howard Marks is co-founder of Oaktree Capital Management, a leading firm in credit, distressed debt, and alternative credit strategies. He is equally well known for his widely read client memos on market cycles, risk, and investor psychology. Marks’s investing philosophy stresses second-level thinking, asymmetric risk/reward, and the importance of understanding where markets sit in the credit cycle.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$43.1M |
| 2 |
Televisa
TV
|
+$31.7M |
| 3 |
STKL
SunOpta
STKL
|
+$30.9M |
| 4 |
Rayonier Advanced Materials
RYAM
|
+$26.2M |
| 5 |
Trip.com Group
TCOM
|
+$17.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$289M |
| 2 |
AABA
Altaba Inc
AABA
|
+$143M |
| 3 |
Alibaba
BABA
|
+$34.2M |
| 4 |
TSMC
TSM
|
+$19.5M |
| 5 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$18.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 16% |
| 2 | Financials | 10.75% |
| 3 | Industrials | 7.64% |
| 4 | Communication Services | 6.17% |
| 5 | Technology | 4.72% |
Similar funds
Howard Marks's Q4 2017 Portfolio in Review
As of Q4 2017, Howard Marks held 213 positions worth $6.38B, down 4.7% from $6.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Howard Marks withdrew a net $2.26B in Q4 2017, closing 10 positions and reducing 22 holdings. Its most notable exit was Allergan plc, an estimated $18.7M position sold in full.
By sector, the portfolio is most concentrated in Utilities at 16% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
Against the trend, Howard Marks opened a new position in Televisa worth $28.6M.
- Howard Marks's largest Q4 2017 buy was Televisa: 1,529,453 shares worth $28.6M.
- Howard Marks added most to Infosys in Q4 2017, an estimated $43.1M increase.
- Howard Marks's biggest Q4 2017 reduction was TRIBUNE MEDIA COMPANY CLASS A, cutting an estimated $289M.
- Howard Marks fully exited Allergan plc in Q4 2017, selling an estimated $18.7M.
- Howard Marks's ten largest holdings make up 40% of its $6.38B portfolio in Q4 2017.
- Howard Marks opened 7 new positions and closed 10 in Q4 2017.
- Howard Marks's portfolio value fell 4.7% quarter-over-quarter to $6.38B.
Based on Oaktree Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.